Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Monsanto Co. -- Ignore unavailable to you. Want to Upgrade?

To: JGoren who wrote (1303)	2/23/1999 12:41:00 AM
From: Michael Kucera	Read Replies (1) \| Respond to of 2539

Jgoren, this is not a direct response to you but something to cheer up the thread: I know of several users of Celebrex who have severe arthritis and they say it is a miracle drug which if you knew these people you would be as elated as i am to hear this b/c they finally stopped complaining about "the pain", oh well this was just some grass-roots fundamental "research" that the prescription data has already confirmed. BTW, I live in St. Louis where MTC is headquartered, so the local paper here, The Post-Dispatch runs frequent articles on Celebrex I will post them in the future for the thread. They are more-invloved than the Reuters stuff I normally see. -Mike

To: JGoren who wrote (1303)	2/23/1999 1:08:00 AM
From: Bindusagar Reddy	Respond to of 2539

I don't have the chart, but they peaked in 5 th week at 300,000 and that was their best week. Unlike Viagra, Celebrex will have incremental prescriptions. You know the reasons are self explanatory. Viagra was tried by even normal people just for curiosity. Once that faded scripts declined and remained flat ever since. One more diff. Viagra was mostly prescribed in 10 pills because of the expense. Celebrex will easily beat Viagra by next month and will continue to grow similar to Lipitor, FYI lipitor had only 30,000 scripts in 5 week of its launch. That gives an idea what Celebrex can bring to MTC. This is for real. Just as wallstreet ignored WLA for sevaral weeks, MTC is being ignored by street. But as the weekly numbers mount, stock should climb steadily. BR